SCHEMBL6499703

SCHEMBL6499703

C[C@@H]1C[C@@H](c2c[nH]c3c(F)c(F)ccc23)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.35
SLC6A4 P31645 1/20 0.35
USP30 Q70CQ3 1/20 0.35
JAK2 O60674 2/20 0.34
JAK1 P23458 2/20 0.34
TYK2 P29597 2/20 0.34
JAK3 P52333 2/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
HTR1D P28221 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
NTRK1 P04629 3/20 0.33
TRPV3 Q8NET8 1/20 0.33
APP P05067 1/20 0.32
CCR2 P41597 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502071 0.91 JAK2 (0.35) GPR119SLC6A4USP30JAK2JAK1
SCHEMBL7090614 0.82 DRD2 (0.49) SLC6A4HTR1D
SCHEMBL6491645 0.82 DRD2 (0.49) SLC6A4HTR1D
SCHEMBL29116463 0.80 KDM4E (0.54) KDM4E
SCHEMBL20111934 0.77 HSD11B1 (0.53) JAK2JAK1TYK2JAK3
SCHEMBL6492379 0.76 SLC6A4 (0.38) SLC6A4MAPTKDM4EHTR1DAPP
SCHEMBL31386163 0.75 KDM4E (0.44) GPR119JAK2JAK1TYK2JAK3
SCHEMBL6492320 0.74 HTR1D (0.37) GPR119JAK1HTR1DNR1H2NR1H3
SCHEMBL1770846 0.73 DPP4 (0.38) GPR119USP30MAPTKDM4ETHRB
SCHEMBL2158777 0.71 MEN1 (0.43) GPR119USP30SMN1; SMN2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844338-B2 Piperidyindoles as serotonin receptor ligands ELI LILLY AND COMPANY (US) 2005-01-18 US disclosed
US-20030225068-A1 Piperidyindoles as serotonin receptor ligands ELI LILLY AND COMPANY 2003-12-04 US disclosed
EP-1286992-A1 PIPERIDYINDOLES AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY (US) 2003-03-05 EP disclosed
WO-2001087881-A1 PIPERIDYINDOLES AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY (US) 2001-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225068-A1 Piperidyindoles as serotonin receptor ligands CNR1, HTR1D, HTR1A GPR119 306/4885SLC6A4 215/4885USP30 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.